Chosa Oncology ABXSAT:CHOSA 31 Market Cap is kr72.93 Mil as of Jun. 29, 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 31/100. Among 1,428 Biotechnology companies, Chosa Oncology AB ranks worse than 87.32% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Chosa Oncology AB's share price for the quarter that ended in Mar. 2026 was kr0.9. Chosa Oncology AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 87.86 Mil. Therefore, Chosa Oncology AB's market cap for the quarter that ended in Mar. 2026 was kr79.08 Mil.
Chosa Oncology AB's quarterly market cap
declined
from Sep. 2025 (kr131.76 Mil) to Dec. 2025 (kr74.95 Mil) but then
increased
from Dec. 2025 (kr74.95 Mil) to Mar. 2026 (kr79.08 Mil).
Chosa Oncology AB's annual market cap
increased
from Dec. 2023 (kr36.59 Mil) to Dec. 2024 (kr59.45 Mil) and
increased
from Dec. 2024 (kr59.45 Mil) to Dec. 2025 (kr74.95 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chosa Oncology AB's Enterprise Value for Today is kr64.16 Mil.
Chosa Oncology AB (XSAT:CHOSA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Chosa Oncology AB Market Cap Related Terms
Chosa Oncology AB Market Cap Historical Data
* Premium members only.
The historical data trend for Chosa Oncology AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:CHOSA vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Chosa Oncology AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chosa Oncology AB Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Chosa Oncology AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Chosa Oncology AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chosa Oncology AB (XSAT:CHOSA) has a Market Cap of kr72.93 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Chosa Oncology AB and its competitors. According to the industry distribution chart, Chosa Oncology AB ranks #1247 out of 1428 companies in the Biotechnology industry, placing it in the top 87.3%.
Is Chosa Oncology AB's Market Cap too high?
Chosa Oncology AB's current Market Cap is kr72.93 Mil. Based on the distribution chart, Chosa Oncology AB ranks #1247 out of 1428 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chosa Oncology AB ranks #1247 out of 1428 companies for Market Cap. This places Chosa Oncology AB in the lower half of its industry. The industry median Market Cap is 114.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Chosa Oncology AB and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chosa Oncology AB's current Market Cap is kr72.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current Market Cap of kr72.93 Mil. The current Market Cap is kr72.93 Mil. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current Market Cap is kr72.93 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:CHOSA has been successfully added to your 
